Your browser doesn't support javascript.
The Role of the Allergist in Coronavirus Disease 2019 Vaccine Allergy Safety: A Pilot Study on a "Hub-and-Spoke" Model for Population-Wide Allergy Service.
Chiang, Valerie; Saha, Chinmoy; Yim, Jackie; Au, Elaine Y L; Kan, Andy K C; Hui, Kong Siu Harris; Li, Tin Sum; Lo, Wing Lam Whitney; Hong, Yuh Dong; Ye, Jiaxi; Ng, Carmen; Ko, Welchie W K; Ho, Carmen T K; Lau, Chak Sing; Quan, Jianchao; Li, Philip H.
  • Chiang V; Division of Clinical Immunology, Department of Pathology, Queen Mary Hospital, Pok Fu Lam, Hong Kong.
  • Saha C; Division of Rheumatology & Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pok Fu Lam, Hong Kong.
  • Yim J; Division of Rheumatology & Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pok Fu Lam, Hong Kong.
  • Au EYL; Division of Clinical Immunology, Department of Pathology, Queen Mary Hospital, Pok Fu Lam, Hong Kong.
  • Kan AKC; Division of Rheumatology & Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pok Fu Lam, Hong Kong.
  • Hui KSH; Division of Rheumatology & Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pok Fu Lam, Hong Kong.
  • Li TS; Division of Rheumatology & Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pok Fu Lam, Hong Kong.
  • Lo WLW; Division of Rheumatology & Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pok Fu Lam, Hong Kong.
  • Hong YD; School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.
  • Ye J; School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.
  • Ng C; School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.
  • Ko WWK; Department of Family Medicine and Primary Healthcare, Hong Kong West Cluster, Hospital Authority, Kowloon, Hong Kong.
  • Ho CTK; Division of Rheumatology & Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pok Fu Lam, Hong Kong.
  • Lau CS; Division of Rheumatology & Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pok Fu Lam, Hong Kong.
  • Quan J; School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.
  • Li PH; Division of Rheumatology & Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pok Fu Lam, Hong Kong. Electronic address: liphilip@hku.hk.
Ann Allergy Asthma Immunol ; 129(3): 308-312.e1, 2022 09.
Article in English | MEDLINE | ID: covidwho-1889189
ABSTRACT

BACKGROUND:

Hong Kong started its coronavirus disease 2019 (COVID-19) vaccination program in February 2021. A territory-wide Vaccine Allergy Safety (VAS) clinic was set up to assess individuals deemed at "higher risk" of COVID-19 vaccine-associated allergies. A novel "hub-and-spoke" model was piloted to tackle the overwhelming demand of services by allowing nonallergists to conduct assessment.

OBJECTIVE:

To evaluate the outcomes of the VAS hub-and-spoke model for allergy assessment.

METHODS:

Records of patients attending the VAS hub-and-spoke Clinics between March and August 2021 were reviewed (n = 2725). We studied the overall results between the Hub (allergist led) and Spoke (nonallergist led) Clinics. The Hub and the Hong Kong West Cluster Spoke Clinic were selected for subgroup analysis as they saw the largest number of patients (n = 1411).

RESULTS:

A total of 2725 patients were assessed under the VAS hub-and-spoke model. Overall, 2324 patients (85.3%) were recommended to proceed with vaccination. Allergists recommended significantly more patients for vaccination than nonallergists (odds ratio = 21.58; P < .001). Subgroup analysis revealed that 881 of 1055 (83.5%) patients received their first dose of COVID-19 vaccination safely after assessment. Among those recommended vaccination, more patients assessed by allergists received their first dose of vaccination (odds ratio = 4.18; P < .001).

CONCLUSION:

The hub-and-spoke model has proven to be successful for the vaccination campaign. This study has illustrated the crucial role of allergists in countering vaccine hesitancy. Results from the study revealed considerable differences in outcomes between allergist-led and nonallergist-led clinics. Precise reasons for these differences warrant further evaluation. We are hopeful that the hub-and-spoke model can be similarly adapted for other allergist-integrative services in the future.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Physician&apos;s Role / Vaccination / Patient Safety / Allergists / COVID-19 Vaccines / Health Services / Hypersensitivity Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Ann Allergy Asthma Immunol Journal subject: Allergy and Immunology Year: 2022 Document Type: Article Affiliation country: J.anai.2022.05.011

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Physician&apos;s Role / Vaccination / Patient Safety / Allergists / COVID-19 Vaccines / Health Services / Hypersensitivity Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Ann Allergy Asthma Immunol Journal subject: Allergy and Immunology Year: 2022 Document Type: Article Affiliation country: J.anai.2022.05.011